Injective is stepping deeper into the world of real-world assets through a new partnership with global investment platform Republic. The collaboration, announced on August 21, aims to bring institutional-grade finance onchain while opening new doors for tokenized private market investing.
Making Tokenized Investments More Accessible
As part of the integration, Republic Wallet now supports Injective assets, giving its 3 million members across 150 countries direct access to Injective-native tokens. A dedicated launchpad for Injective-based projects is also on the way, providing startups and institutions with access to Republic’s vast investor network—spanning both retail and accredited participants.
Republic isn’t new to this space. The company has built a strong reputation in tokenization and private markets, having helped more than 3,000 ventures secure over $3 billion in funding. Its portfolio includes high-profile unicorns like SpaceX, Robinhood, and Carta.
Through this partnership, Republic is moving beyond its role as an Injective validator to take a more hands-on approach, focusing on growing onchain fundraising and making tokenized investment products more widely available.
Building Bridges for Institutional Adoption
What makes this partnership particularly notable is Republic’s regulatory status. As a FINRA-registered platform with approvals across the U.S., UK, EU, and Asia, Republic brings compliance and institutional credibility to Injective’s finance-focused blockchain.
Together, the two platforms are blending Republic’s tokenization expertise with Injective’s high-performance infrastructure already used for real-world asset markets like tokenized Nvidia chips, equities, and structured financial products.
The tokenization market itself is booming, expected to grow from $35 billion today to $50 billion by year’s end. With Injective’s speed and Republic’s regulatory framework, the stage is set for rapid co-development of new tokenized products that could draw both institutional and retail investors.
Why This Matters for Injective
Injective has been making steady strides in linking traditional finance with decentralized markets. Recent launches such as the first onchain Digital Asset Treasury with tokenized ETH exposure and markets for Nvidia’s H100 chips and equity-linked products show how quickly its ecosystem is evolving.
By joining forces with Republic, Injective gains a stronger bridge to mainstream finance while positioning itself as a leader in democratizing blockchain-based private investment opportunities. For investors, it signals that tokenized assets are moving from concept to reality, with the potential to reshape how capital flows in global markets.
